Despite the identification of several candidate genes and causative CNVs, the vast majority of ASD cases remain unexplained.
Massively parallel sequencing identified rare SNVs in 13.63% of the patients.
Our results underscore the difficulty of the molecular diagnosis of ASD and confirm its genetic heterogeneity.